治疗肖格伦综合征的新策略
Alexander V Blagov1, Vasily V Kashtalap2, Ksenia O Lapshina3
1Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, Moscow 125315, Russia. al.blagov2014@gmail.com.
Cellular and molecular biology (Noisy-le-Grand, France)
|April 26, 2025
概括
对于Sjögren的新兴疗法
科学领域:
- 免疫学和风湿病学
- 自身免疫性疾病治疗方法 治疗方法
背景情况:
- 肖格伦综合征 (SS) 是一种自身免疫性疾病,导致干燥和疲劳.
- 目前对SS的治疗主要是治疗症状.
- 病原发生涉及复杂的免疫细胞和细胞因子失调.
研究的目的:
- 审查Sjögren综合征的新型治疗策略.
- 探索针对SS.中的特定分子通路的治疗方法.
- 提供新兴疗法及其潜在临床影响的概述.
主要方法:
- 文献综述SS的药物开发近期的进展.
- 对新生物药物的临床试验的分析.
- 检查调节免疫通路的向疗法.
主要成果:
- 一些新的生物药物正在开发中,用于SS.
- 向治疗侧重于调节B细胞,T细胞和细胞因子.
- 新兴的治疗方法显示出更有效的SS管理的潜力.
结论:
- 新的治疗策略比目前的SS症状管理更有希望.
- 针对特定的分子通路可能会导致改善患者的治疗结果.
- 进一步的研究和临床试验对于验证这些新型治疗方法至关重要.
相关概念视频
Open Angle Glaucoma: Treatment
358
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
358
Autoimmune Disorders
313
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
313
Myasthenia Gravis: Overview and Treatment
958
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
958
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
97
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
97


